ActivMab®
Discovery Solutions
Let us help you move faster from the bench to the clinic.
OUR TECHNOLOGY
ActivMab® platform enables the discovery and development of antibodies with high selectivity and novel mechanisms of action against complex membrane proteins.
Vaccinex’s Next Generation ActivMAb® Technology Published in mAbs, a Leading Biotech Journal, and Validated in OmniAb Proof-of-Concept Collaboration
Learn more by viewing our On-demand Webinar:
Antibody Discovery for Challenging Targets Powered by ActivMab® Technology
Vaccinex has developed a proprietary mammalian based antibody discovery platform with unique multi-pass membrane target capabilities.
Antigen Virus, In Vivo Discovery, In Vitro Discovery & Protein Optimization
Antigen Virus
Our technology allows for the expression of multi-pass membrane proteins in a format suitable for use with both in vitro and in vivo Antibody Discovery methods.
In Vivo Discovery
Antigen virions can be used to immunize multiple species for Antibody Discovery.
In Vitro Discovery
The antigen-expressing virions enable antibody discovery on complex antigens using methods that are utilized for simple purified proteins.
Protein Optimization
Our proprietary technology with poxvirus is built on years of experience creating recombinant libraries in Vaccinia Virus.